INS and type 2 diabetes mellitus: These GLP-1 RA/basal insulin combinations may be particularly advantageous for obese patients with long-standing type 2 diabetes for mitigating the weight gain associated with insulin therapy, improving glycaemic control, and/or reducing insulin requirements.